Lv11
30 积分 2024-06-24 加入
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
2小时前
待确认
A tale of two antibodies: obinutuzumab versus rituximab
2个月前
已完结
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy
3个月前
已完结
Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases
5个月前
已完结
Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study
5个月前
已完结
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
5个月前
已完结
Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy
5个月前
已完结
皖公网安备34019202002308
